Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study. - Wikidata - awgldk - TriplyDB

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

http://www.wikidata.org/entity/Q30479456

about

Lymphangioleiomyomatosis: differential diagnosis and optimal management Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.Involvement of lymphatics in lymphangioleiomyomatosis Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.Lung Transplantation for Lymphangioleiomyomatosis in Japan.Pulmonary hypertension in parenchymal lung disease.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.Personalized echocardiography: clinical applications of advanced echocardiography and future directions.Pulmonary hypertension secondary to interstitial lung disease.The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?Recent advances in the management of lymphangioleiomyomatosis.Pulmonary Vascular Shunts in Exercise-Intolerant Patients with Lymphangioleiomyomatosis Histopathologische Aspekte der pulmonalen Hypertonie

P2860

Q27022412-52AE2F6D-1428-4BD1-B38D-7CECD9CFF01E Q28084975-D7BE197C-9ACE-4901-BF87-2C510F7E7DA3 Q33587163-988C8EEF-DA8F-4E50-BCC4-514BC723F98D Q33905090-39EB9D62-CBD0-4DBC-9E9C-347CCBA281A8 Q33905141-463D157F-6F8B-4020-8018-21CCCDED49D3 Q34001118-2146CB1B-2167-478F-95C4-1ED187504EFB Q34129641-1622C236-A8CA-4822-86C8-2F0606208F2C Q34536450-2B642D6F-3243-4039-8000-44A8E8811639 Q35895325-08AB656C-A141-4144-B515-93BA22165188 Q36328903-BBF55BC9-F01F-477C-911B-EABE10E355B0 Q37149062-9FA4507A-1CF5-461A-883D-6A8EB7901C74 Q37397803-1C88D559-9910-4ACB-8F7A-EFCF1BC86E0C Q37818213-171A4B13-4678-4296-8748-E179B4A4A7F6 Q37867667-DFB2DFD4-EB17-49E7-BDE5-B3ACBC3FF6E8 Q38372196-CA04700C-857F-4169-8BE0-A2EC13A64A54 Q39279796-63925623-02E7-44BA-A06D-1C1EA7F1AF44 Q46275196-1C375071-D499-4EA5-8A71-CE419BC93E90 Q47370738-EB5A5E8B-D33C-46A1-9D49-7855D5FA90A6 Q50092007-7ADDCACC-6254-4A13-B7E4-FF2584A46504 Q55483958-53A42B69-DC9C-4A95-A1F3-2C4BC478E477 Q55981834-096A8B16-FC59-4021-978F-24FFE573052F Q57824017-519CEA74-4117-45A0-BACC-18616CDC367A

P2860

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

http://www.wikidata.org/entity/Q30479456

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@ast

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@en

type

label

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@ast

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@en

prefLabel

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@ast

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@en

P1433

Q30479456-BBD3998D-3B40-401E-8188-A1F10D6F7703

P1476

Q30479456-E31B4D07-23EA-47BE-B87C-937A0F35641D

P2093

Q30479456-0EAF30D7-447E-463E-BA26-D4705A612020

Q30479456-2C540920-A856-4CA3-AE34-C9D895E1BEA1

Q30479456-44701365-F490-4972-B1B6-2C50B0CAA813

Q30479456-AF88FCD1-57C1-4D1C-ACFB-36440C67A5B1

Q30479456-B2A06C22-214A-48E6-B7DA-31ECC06E1D5F

Q30479456-FDE01E30-735F-467D-A9EB-2AE12A982F90

P2860

Q30479456-181178C1-D203-43E0-AF91-2E9B1CDD043D

Q30479456-3F808417-5848-47D7-B12D-DCFB410F9B61

Q30479456-42061AA7-2161-4B68-8BFC-5BC05F644E7E

Q30479456-64340581-EE65-4B4C-8BEA-DD96AF11F876

Q30479456-73556E3E-D0A7-438D-9310-B92AB5AE4FC6

Q30479456-73CFB05E-8CE3-4C0C-B390-91FE040F275B

Q30479456-804FFBE9-B992-4905-8AF4-5C2A835A80CF

Q30479456-8464C859-1F4F-4BF4-9B2C-DC7315039738

Q30479456-895C189F-7468-442A-A866-9D4306CDBA23

Q30479456-9991E6C8-F9B8-4E20-87C0-070FE6B53479

P304

Q30479456-E0E6BF31-660E-46C6-8E52-910967E7DAC2

P31

Q30479456-6E2B1575-27AD-4178-86EA-CB52A511262A

P356

Q30479456-39CB2CF0-4D81-4953-9E82-66FB3D4FF136

P407

Q30479456-D5C44AAA-59EA-44BD-872F-EB75F6B956C3

P433

Q30479456-0C235C65-E254-4247-9219-7E03A3909BA3

P478

Q30479456-70769A41-CBE8-4B50-BDA4-5070BCC21317

P577

Q30479456-EB0D5F40-4CB8-486F-90A1-DECB2ADC36AE

P5875

Q30479456-4CF2DF2D-84DB-4DCD-8D29-B0BC6D2A235D

P698

Q30479456-F9ECB4E8-ABC0-4600-8D9E-2962DD3C787E

P921

Q30479456-E6493C38-A84B-4F76-9BE0-360BCCDD4734

P932

Q30479456-BD4B7938-BBF9-45E5-9E86-77134DB52FB1

P356

P1433

P1476

Pulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.

@en

P2093

Angelo M Taveira-DaSilva

http://www.w3.org/2001/XMLSchema#string

Charles W Birdsall

http://www.w3.org/2001/XMLSchema#string

Joel Moss

http://www.w3.org/2001/XMLSchema#string

Olanda M Hathaway

http://www.w3.org/2001/XMLSchema#string

Vandana Sachdev

http://www.w3.org/2001/XMLSchema#string

Yukitaka Shizukuda

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of Spirometry, 1994 Update. American Thoracic Society

Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures.

Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.

Pulmonary hypertension in chronic obstructive pulmonary disease.

The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia.

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.

P304

1573-1578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.07-1205

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5954683

http://www.w3.org/2001/XMLSchema#string

P698

17890459

http://www.w3.org/2001/XMLSchema#string

P921

echocardiography

P932

2946895

http://www.w3.org/2001/XMLSchema#string